Asset Management One
GBT

Asset Management One’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Asset Management One’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,483
Closed -$130K – 1037
2017
Q1 		$130K Buy
+3,483
New +$87.7K ﹤0.01% 974
2016
Q4 		– Sell
-130,374
Closed -$2.67M – 1252
2016
Q3 		$2.67M Sell
130,374
-12,817
-9% -$244K 0.04% 512
2016
Q2 		$2.31M Buy
143,191
+53,532
+60% +$1.08M 0.03% 556
2016
Q1 		$1.34M Buy
89,659
+14,084
+19% +$250K 0.02% 776
2015
Q4 		$2.46M Sell
75,575
-3,573
-5% -$155K 0.04% 537
2015
Q3 		$3.16M Buy
+79,148
New +$3.73M 0.05% 467

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Asset Management One's GBT Position: Q2 2017 in Review

Asset Management One sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2017, closing a stake of 3,483 shares — an estimated $130K sold.

Asset Management One first reported a position in GBT in Q3 2015 and held it in 6 quarters. The position peaked at $3.16M in Q3 2015. 134 funds tracked by Wall St. Rank hold GBT as of Q2 2017.

  • Asset Management One reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
  • Asset Management One sold 3,483 Global Blood Therapeutics, Inc. shares in Q2 2017, an estimated $130K.
  • Asset Management One first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 6 quarters.
  • Asset Management One's Global Blood Therapeutics, Inc. position peaked at $3.16M in Q3 2015.
  • 134 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2017.

Based on Asset Management One's 13F filing for Q2 2017, filed 14 Aug 2017.